Approved Study Database

Ref. No. Scientific Title Principal investigator
2012.470 A randomised double-blinded placebo-controlled trial of combined vitamin D3 and K2 for bone health Prof Wang Chi Chiu, Ronald
2012.468 Endoscopic Dacryocystorhinostomy as Primary versus Secondary Treatment in Acute Dacryocystitis Dr LI Yuen Mei, Emmy
2012.451 An Open-Label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection Professor Leung Ting Fan
2012.450 Can transcutaneous electrical nerve stimulation (TENS) improve pressure ulcer healing in older persons? A randomized double-blind controlled trial. Dr Lee Shun Wah Jenny
2012.444 A phase IIb randomised controlled trial of the effect of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients on ICU-free days Prof Gomersall Charles
2012.443 THE USE OF PILLCAM ESOPHAGUS IN TRIAGING PATIENTS PRESENTED WITH UPPER GASTROINTESTINAL BLEEDING Prof. SUNG Joseph
2012.442 Randomised, double-blinded and placebo-controlled trial of a modified classical Chinese medicine formula DBT for general well being and bone health of postmenopausal women in Hong Kong Prof Wong Lai-yi, Eliza
2012.437 A local Phase IV, multicenter, open-label study to evaluate early add-on Vildagliptin in patients with Type 2 diabetes inadequately controlled Metformin Dr. WONG Carmen
2012.430 A Global Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer (Asian Phase 3 Study) Prof. MOK Tony Shu Kam
2012.426 Randomized prospective trial, single blinded, investigating impact of operating theatre orientation in addition to preoperative education on patient anxiety and outcome Dr Tan Olivia
2012.424 Prevalence and clinical significance of nonalcoholic fatty liver disease in patients with type 2 diabetes: A prospective cohort study using controlled attenuation parameter and liver stiffness measurements Dr. WONG Wai Sun
2012.422 A phase II, multicenter, single-arm study of oral LDK378 in adult patients with ALK-activated non-small cell lung cancer previously treated with chemotherapy and crizotinib Prof. MOK Tony Shu Kam
2012.419 An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment with Siltuximab in Subjects with Multicentric Castleman's Disease Dr. WONG Raymond Siu Ming
2012.417 A randomized, double-blind, 12-week treatment, parallel-group study to evaluate the efficacy and safety of QMF149 (150 _g/160 _g o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 _g/500 _g b.i.d.) in patients with chronic obstructive pulmonary disease Dr. Kwan Hoi Yee
2012.415 A randomized, double-blind, 12-week treatment, parallel-group study to evaluate the efficacy and safety of QMF149 (150 _g/160 _g o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 _g/500 _g b.i.d.) in patients with chronic obstructive pulmonary disease Prof. Hui Shu Cheong David
2012.414 Management of myocardial injury After NoncArdiac surGEry Trial Dr CHAN Matthew Tak Vai
2012.409 Randomized Multi-Center Study Comparing No Drainage to Preoperative Biliary Drainage Using Metal Stents in Patients with Resectable Pancreatic or Periampullary Cancer Prof. LAU James Y.W.
2012.408 A Multi-Center, Prospective, Randomized Study Comparing Removable, Self-Expanding Metal Stents to Plastic Stents for the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis Prof. LAU James Y.W.
2012.407 The BALANCED Anaesthesia Study: The Influence of Anaesthetic Depth on Patient Outcome after Major Surgery Dr. CHAN Matthew Tak Vai
2012.406 A Phase 3 Randomized, Open-Label Study of Ponatinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Dr. Wong Raymond Siu-Ming
2012.405 A Phase 3, Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-Group Trial with an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults with Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura) Dr WONG Siu Ming Raymond
2012.397 Clinical bioequivalence study on two zolpidem formulations Professor Lee Hon-leung, Vincent
2012.388 Effectiveness of Stretching Exercise on Prevention of Noctural Calf Cramp in Chinese Elderly : A Randomized Controlled Trial Dr Lee Man Kei
2012.383 An open-labelled study to investigate Deep Brain Stimulation as treatment for medically refractory epilepsy Prof. POON Wai Sang
2012.371 Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma: A Multicenter, Randomized, Controlled Trial Prof. Sung Joseph
2012.370 INGEVITY™ Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study Dr. CHAN Gary Chin Pang
2012.368 A multicentre, open-label, long-term, safety, tolerability, and efficacy study of retigabine immediate-release (IR) in Asian adults with partial onset seizures (extension of study RTG114855) Dr Kwan Patrick Kwok Leung
2012.367 A randomized controlled trial on endoscopic ultrasound-guided celiac ganglion neurolysis versus percutaneous celiac plexus neurolysis in patients with inoperable pancreatic cancer. Dr. TEOH Anthony Yeun Bun
2012.362 Is it safe to take Danshen-Gegen product with Warfarin or Aspirin? – a pilot study in human subjects Professor ZUO Joan Zhong
2012.357 An open-label trial of 48-week peginterferon alfa-2a (PEGASYS) to assess the sustained response of chronic hepatitis B patients with HBeAg seroconversion on nucleot(s)ide analogue therapy Prof. WONG Grace Lai Hung
2012.354 A randomized trial of chronic disease self management and cognitive training programme to improve diabetic control in older cognitive impaired outpatients Prof. KWOK Timothy
2012.352 A multi-centre long-term follow-up study to assess the durability of sustained virologic response in alisporivir-treated chronic Hepatitis C patients Dr. HUI Aric Josun
2012.351 Open liver resection with or without vascular inflow occlusion for hepatocellular carcinoma: a randomized controlled trial Dr Lee Kit-fai
2012.350 A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients Dr. HUI Aric Josun
2012.348 Prediction of outcome of chemotherapy side effect in cancer patients: a prospective development and validation of a multi-symptom chemotherapy risk assessment model in a Chinese population Ms. MAK Suzanne So Shan
2012.343 A randomized controlled trial of bilateral movement-based computer games training to improve motor function of upper limb and quality of life in Sub-acute stroke patient Ms. LAM Stefanie So Ling
2012.339 Pharmacist Intervention and Screening of Potentially Inappropriate Medications on Hospitalized Geriatric Patients in Hong Kong Mr Mak Wun Cheung
2012.338 Sequential bilateral cochlear implantation: Prospective and retrospective study in adults and children Miss NG Iris H. Y.
2012.336 Psychoeducational interventions for gynecological cancer patients in Hong Kong Ms Chow Ka Ming
2012.333 A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of BA058 for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women with Severe Osteoporosis and at Risk of Fracture Dr Liu Po Lung Paul
2012.332 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events Prof. YU Cheuk Man
2012.331 A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy In Patients with Clinically Evident Cardiovascular Disease Professor Tomlinson Brian
2012.330 A randomized, double-blind, crossover study to assess the effects of LCZ696 and valsartan in Asian patients with salt-sensitive hypertension Prof. Tomlinson Brian
2012.329 A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination with Metformin in Subjects with Type 2 Diabetes Dr. OZAKI Risa
2012.328 Clinical Bioequivalence Study on Two Paracetamol Formulations Professor Lee Hon-leung, Vincent
2012.323 The value of four-dimensional hystero-salpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency Prof. LI Tin Chiu
2012.319 The role of aldehyde dehydrogenase 2 (ALDH2) in nitrite mediated cardioprotection in patients undergoing first-time elective coronary artery bypass surgery Prof. UNDERWOOD Malcolm J.
2012.315 A phase Ib dose escalation/randomized phase II, multicenter, open-label study of BYL719 in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma Prof. MA Brigette Buig Yue
2012.314 A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination with Metformin in Subjects with Type 2 Diabetes Prof. TOMLINSON Brian
2012.313 guardianTM4, Safety and Efficacy of turoctocog alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients with Haemophilia A Dr. SHING Ming Kong

Page 229 of 263.